Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,695,700 | 3,047,800 | 2,017,600 | 969,200 | 3,593,200 |
| Depreciation Amortization | 682,700 | 505,300 | 325,100 | 149,700 | 600,400 |
| Income taxes - deferred | -175,000 | -56,800 | -30,200 | 8,900 | -145,600 |
| Accounts receivable | -241,400 | -238,100 | -65,000 | -160,000 | 29,000 |
| Other Working Capital | 125,200 | -654,100 | -411,500 | -145,400 | -450,400 |
| Other Operating Activity | 500,000 | 401,200 | 178,000 | 193,400 | 292,800 |
| Operating Cash Flow | $4,587,200 | $3,005,300 | $2,014,000 | $1,015,800 | $3,919,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -616,100 | -434,000 | -263,700 | -126,900 | -643,000 |
| Net Acquisitions | -1,200,000 | -900,000 | -600,000 | -300,000 | -1,048,800 |
| Purchase Of Investment | -7,913,200 | -5,631,700 | -3,833,300 | -1,914,400 | -6,864,900 |
| Sale Of Investment | 7,378,900 | 5,185,800 | 2,823,600 | 1,181,100 | 4,063,000 |
| Purchase Sale Intangibles | -111,600 | -110,400 | 0 | -28,600 | -15,400 |
| Other Investing Activity | -134,400 | -123,200 | -65,900 | -43,000 | -59,900 |
| Investing Cash Flow | $-2,484,800 | $-1,903,100 | $-1,939,300 | $-1,203,200 | $-4,553,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,930,500 |
| Debt Repayment | -2,700 | -2,700 | N/A | N/A | -2,100 |
| Common Stock Issued | -8,500 | -12,400 | -21,900 | N/A | -70,900 |
| Common Stock Repurchased | -1,000,000 | -348,900 | 0 | 0 | -5,000,000 |
| Other Financing Activity | -41,400 | 37,900 | 1,100 | -5,000 | -74,400 |
| Financing Cash Flow | $-1,052,600 | $-326,100 | $-20,800 | $-5,000 | $783,100 |
| Exchange Rate Effect | -31,300 | 700 | 100 | 15,100 | -45,800 |
| Beginning Cash Position | 1,308,000 | 1,308,000 | 1,308,000 | 1,308,000 | 1,204,900 |
| End Cash Position | 2,326,500 | 2,084,800 | 1,362,000 | 1,130,700 | 1,308,000 |
| Net Cash Flow | $1,018,500 | $776,800 | $54,000 | $-177,300 | $103,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,587,200 | 3,005,300 | 2,014,000 | 1,015,800 | 3,919,400 |
| Capital Expenditure | -616,100 | -434,000 | -263,700 | -126,900 | -643,000 |
| Free Cash Flow | 3,971,100 | 2,571,300 | 1,750,300 | 888,900 | 3,276,400 |